1. Chen, M. R., Chang, T. Y., Chiu, N. C., Chi, H., Yang, K. D., Chang, L., ... and Lee, Y. J. (2020). Validation of genome-wide associated variants for Kawasaki disease in a Taiwanese case–control sample. Scientific Reports, 10(1), 1-5. 2. Chen, M. R., Kuo, H. C., Lee, Y. J., Chi, H., Li, S. C., Lee, H. C., and Yang, K. D. (2021). Phenotype, susceptibility, autoimmunity, and immunotherapy between Kawasaki disease and coronavirus disease-19 associated multisystem inflammatory syndrome in children. Frontiers in immunology, 12, 632890. 3. Guo, M. M. H., Yang, K. D., Liu, S. F., & Kuo, H. C. (2022). Number of Kawasaki Disease Admissions Is Associated with Number of Domestic COVID-19 and Severe Enterovirus Case Numbers in Taiwan. Children, 9(2), 149. 4. Shiue, S. J., Rau, R. H., Shiue, H. S., Hung, Y. W., Li, Z. X., Yang, K. D., and Cheng, J. K. (2019). Mesenchymal stem cell exosomes as a cell-free therapy for nerve injury–induced pain in rats. Pain, 160(1), 210-223. 5. Tsai, Y. G., Yang, K. D., Wen, Y. S., Hung, C. H., Chien, J. W., and Lin, C. Y. (2019). Allergen‐specific immunotherapy enhances CD8+ CD25+ CD137+ regulatory T cells and decreases nasal nitric oxide. Pediatric Allergy and Immunology, 30(5), 531-539.